Login / Signup

Long-term follow-up of patients with myasthenia gravis treated with low-dose rituximab.

Fiona ChanAndrew SwayneDavid GillisMichael WalshRobert D HendersonPamela A McCombeRichard C WongStefan Blum
Published in: Journal of neurology, neurosurgery, and psychiatry (2018)
Keyphrases
  • myasthenia gravis
  • low dose
  • diffuse large b cell lymphoma
  • high dose
  • hodgkin lymphoma
  • chronic lymphocytic leukemia
  • newly diagnosed